Anzeige
Mehr »
Login
Samstag, 28.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Gold – der nächste große Gewinner? Warum Analysten diese Aktie im Blick haben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
371 Leser
Artikel bewerten:
(2)

Marula Mining Plc - Issue of Equity

Marula Mining Plc - Issue of Equity

PR Newswire

LONDON, United Kingdom, August 31

Marula Mining PLC

("Marula'' or the "Company")

31 August 2023

Issue of Equity, PDMR Shareholding

Marula Mining (AQSE: MARU), an African focused mining and development company, announces that following completion of the Phase 1 Exploration Program at the Kinusi Copper Mine ("Kinusi" or the "Project") as announced 29 June 2023, the Company has issued 613,876 new ordinary shares of 0.01 pence each ("Ordinary Share") ("Fee Shares") at an issue price of approximately 12.82 pence per new Ordinary Share (based on the 30 day VWAP of the Company's Ordinary Shares) to Takela Mining Tanzania Limited ("Takela") in lieu of the US $100,000 in shares owed to Takela following the completion of an initial exploration program at Kinusi, as per the terms of agreement with Takela announced on 20 February 2023.

Following the issuance of the Fee Shares, Takela holds 4,092,626 ordinary shares in the Company, representing approximately 3.13 % of the Company's issued share capital.

Edward Ruheni, General Manager Operations East Africa of the Company is a substantial shareholder and director of Takela.

Admission

Application has been made for the Fee Shares to be admitted to trading on the Aquis Stock Exchange Growth Market on or around 6 September 2023 ("Admission") and will rank pari passu with the ordinary shares of the Company in issue.

Total voting rights

Following Admission, the Company's issued share capital will comprise 130,798,624 ordinary shares of 0.01p each, with each share carrying the right to one vote, therefore the total number of voting rights in the Company will be 130,798,624. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The Directors of Marula are responsible for the contents of this announcement. This announcement contains inside information for the purposes of UK Market Abuse Regulation.

About Marula Mining

Marula Mining (AQSE: MARU) is an African focused battery metals investment and exploration company and has interests in several high value mine projects in Africa; Blesberg Lithium and Tantalum Mine in South Africa, Nkombwa Hill Project in Zambia and Kinusi Copper Mine, Bagamoyo Graphite Project and Nyorinyori Graphite Project in Tanzania. As we advance operations at these battery metals focused projects, Marula will continue to build and expand its interests in other high-quality projects in Africa.

Marula's strategy is to identify and invest in advanced and high-value mining projects throughout East, Central and Southern Africa that the Directors believe would deliver returns for its shareholders. The Board and management team aims to establish Marula as a socially and environmentally responsible, sustainable, and profitable producer of critical metals and commodities that are of increasingly strategic importance to modern technologies and the global economy.

Marula's shares are traded on the AQUIS Stock Exchange (AQSE), Marula is exploring opportunities to admit its shares to trading on AIM, the market operated by the London Stock Exchange Group plc, Kenya's Nairobi Securities Exchange and South Africa's Johannesburg Stock Exchange.

For enquiries contact:

Marula Mining PLC

Jason Brewer,

Chief Executive Officer

Faith Kinyanjui Mumbi

Investor Relations

Email: jason@marulamining.com

Email: info@marulamining.com

AQSE Corporate Adviser

Cairn Financial Advisers LLP,

Liam Murray / Ludovico Lazzaretti

+44 (0)20 7213 0880

Broker

Peterhouse Capital Limited,
Charles Goodfellow / Duncan Vasey

+44 (0)20 7469 0930

Financial PR and IR

BlytheRay

Tim Blythe / Megan Ray / Said Izagaren

+44 (0)20 7138 3204

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Edward Ruheni

2

Reason for notification

a.

Position/Status

General Manager Operations East Africa of the Company is a substantial shareholder and director of Takela.

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Marula Mining plc

b.

LEI

2138002UCKAEBPYWVT15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Ordinary shares of 0.01 pence each

ISIN: GB00BNBS4S95

b.

Nature of the transaction

Issue to Takela of the Fee Shares following completion of an initial exploration program at Kinusi

c.

Price(s) and volume(s)

Price(s) Volume(s)

12.82p 613,876

d.

Aggregated information

- Aggregated Volume

- Price

N/A

e.

Date of the transaction

31 August 2023

f.

Place of the transaction

AQSE




© 2023 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.